:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Po‐Hung Lin, Jason Yongsheng Chan, Peiyong Guan, Jing Han Hong, Abner Herbert Lim, Cedric Chuan‐Young Ng, Joe Poh Sheng Yeong, Jing Yi Lee, Wei Liu, Jeffrey Chun Tatt Lim, See‐Tong Pang, Bin Tean Teh
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	The Journal of Pathology
Online Access:	https://pathsocjournals.onlinelibrary.wiley.com/doi/10.1002/path.6349
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tumor immune microenvironment in odontogenic carcinomas: Evaluation of the therapeutic potential of immune checkpoint blockade
by: Kyu‐Young Oh, et al.
Published: (2024)

Targeting the tumor microenvironment in cholangiocarcinoma to improve immune checkpoint blockade: potential strategies and translational pre‐clinical models
by: Maria‐Danae Jessel, et al.
Published: (2025)

Hepatitis B virus‐related hepatocellular carcinoma exhibits distinct intratumoral microbiota and immune microenvironment signatures
by: Yuanjie Liu, et al.
Published: (2024)

Molecular subtypes of lung adenocarcinoma present distinct immune tumor microenvironments
by: Hironori Fukuda, et al.
Published: (2024)

Host ANGPTL2 establishes an immunosuppressive tumor microenvironment and resistance to immune checkpoint therapy
by: Shinsei Yumoto, et al.
Published: (2024)

Calreticulin, a potential coregulator of immune checkpoints and biomarker associated with tumor microenvironment and clinical prognostic significance in breast invasive carcinoma
by: Jiali Lin, et al.
Published: (2024)

A single gene mutation predicts response to immune checkpoint blockade in ovarian clear cell carcinoma
by: Matheus Henrique Dias, et al.
Published: (2025)

Cyclin‐dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple‐negative breast cancer by affecting the immune microenvironment
by: Jiayi Wu, et al.
Published: (2024)

KMT2D deficiency potentiates antitumor immunity and sensitizes immune checkpoint blockade in urologic cancers
by: Yuedian Ye, et al.
Published: (2025)

Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor
by: Georges Gebrael, et al.
Published: (2024)

Establishment of an in situ model to explore the tumor immune microenvironment in head and neck squamous cell carcinoma
by: Congxian Lu, et al.
Published: (2024)

The roles of algal polysaccharides in modulating tumor immune microenvironment.
by: Wu, Yinfeng, et al.
Published: (2025)

Plasma EBV quantification is associated with the efficacy of immune checkpoint blockade and disease monitoring in patients with primary pulmonary lymphoepithelioma‐like carcinoma
by: Yu‐Min Zhong, et al.
Published: (2024)

Prognostic biomarkers associated with immune checkpoint inhibitors in hepatocellular carcinoma
by: Xiu Chen, et al.
Published: (2024)

Blood‐based biomarkers in soft tissue sarcoma: Implications for immune checkpoint inhibitor therapy
by: Brie‐Anne Mannah, et al.
Published: (2025)

Comparing survival in trial‐ versus routine‐care advanced urothelial cancer patients on immune checkpoint blockade
by: Lucy S. Wang, et al.
Published: (2024)

Exosomes in tumor‐stroma crosstalk: Shaping the immune microenvironment in colorectal cancer
by: Yawei Zhang, et al.
Published: (2024)

Cancer heterogeneity explored through immune cell deconvolution of the tumor microenvironment
by: Limin Jiang, et al.
Published: (2026)

Peripheral immune biomarkers for immune checkpoint inhibition of solid tumours
by: Meghali Goswami, et al.
Published: (2024)

Evolution of liver function during immune checkpoint inhibitor treatment for hepatocellular carcinoma
by: Katharina Pomej, et al.
Published: (2024)

Shaping the immune‐suppressive microenvironment on tumor‐associated myeloid cells through tumor‐derived exosomes
by: Hongmei Wang, et al.
Published: (2024)

Deciphering the tumor immune microenvironment: Microscale measurements for precision detection and multidimensional analysis
by: Lu Wang, et al.
Published: (2025)

Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy
by: Shilong Zhao, et al.
Published: (2026)

Different characteristics of the tumor immune microenvironment among subtypes of salivary gland cancer
by: Yoshiaki Nagatani, et al.
Published: (2024)

Efficacy of immune checkpoint inhibitor combination therapy prior to nephrectomy in advanced renal cell carcinoma: A retrospective pilot study
by: Sho Kiyota, et al.
Published: (2024)

Fatal tumoral hemorrhage from brain metastases of renal cell carcinoma after stereotactic radiotherapy and immune checkpoint inhibitor and vascular endothelial growth factor‐targeted therapy combinations
by: Kaoruko Iwasa, et al.
Published: (2024)

Challenges and advances of immune checkpoint therapy
by: Lingyu Li, et al.
Published: (2024)

LTBR acts as a novel immune checkpoint of tumor‐associated macrophages for cancer immunotherapy
by: Liang Wang, et al.
Published: (2024)

Papillary renal cell carcinoma with high‐ ABCC2 shows an immune‐evasive profile associated with favorable response to immunotherapy
by: Vincent Francis Castillo, et al.
Published: (2025)

Impacts of immune microenvironment on musculoskeletal health
by: Ren Xu
Published: (2024)

Effect of age on treatment outcomes of first‐line immune checkpoint inhibitor combination therapy for previously untreated advanced renal cell carcinoma
by: Hiroki Ishihara, et al.
Published: (2025)

Comprehensively analysis of IL33 in hepatocellular carcinoma prognosis, immune microenvironment and biological role
by: Lifang Wei, et al.
Published: (2024)

Exploring the interplay between bisphenol A exposure, the immune microenvironment and hepatocellular carcinoma progression
by: Qi Liu, et al.
Published: (2024)

Targeting the crosstalk between glutamine metabolism and tumor immune microenvironment for lung cancer immunotherapy
by: Jingyang Li, et al.
Published: (2025)

Paraptosis‐related genes regulate tumor immune microenvironment and predict prognosis in breast cancer
by: Ziyi Dong, et al.
Published: (2025)

Methodology of high‐dimensional flow cytometry in monitoring immune microenvironment of pituitary neuroendocrine tumors
by: Marina Yu Loguinova, et al.
Published: (2025)

Primary tracheal adenoid cystic carcinoma: A case report and analysis of the tumor immune microenvironment using single cell RNA sequencing
by: Wenda Ye, et al.
Published: (2024)

The impact of Foxp3 + regulatory T‐cells on CD8 + T‐cell dysfunction in tumour microenvironments and responses to immune checkpoint inhibitors
by: Mikhaël Attias, et al.
Published: (2024)

Vasculogenic mimicry regulates immune infiltration and mutational status of the tumor microenvironment in breast cancer to influence tumor prognosis
by: Shurong Zheng, et al.
Published: (2024)

Mechanism research of non‐coding RNA in immune checkpoint inhibitors therapy
by: Jie Bian, et al.
Published: (2024)